{"id":"https://openalex.org/W7127044335","doi":"https://doi.org/10.1111/aos.70069","title":"Beyond drug price: A comparison of overall costs of anti\u2010vascular endothelial growth factor therapy alternatives for neovascular age\u2010related macular degeneration in Norway","display_name":"Beyond drug price: A comparison of overall costs of anti\u2010vascular endothelial growth factor therapy alternatives for neovascular age\u2010related macular degeneration in Norway","publication_year":2026,"publication_date":"2026-02-01","ids":{"openalex":"https://openalex.org/W7127044335","doi":"https://doi.org/10.1111/aos.70069","pmid":"https://pubmed.ncbi.nlm.nih.gov/41622479"},"language":"en","primary_location":{"id":"doi:10.1111/aos.70069","doi":"https://doi.org/10.1111/aos.70069","is_oa":true,"landing_page_url":"https://doi.org/10.1111/aos.70069","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aos.70069","source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aos.70069","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5124742882","display_name":"Jacopo F. T. L\u00f8kken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Jacopo F. T. L\u00f8kken","raw_affiliation_strings":["Centre for Educational Measurement, Faculty of Educational Sciences University of Oslo  Oslo Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Educational Measurement, Faculty of Educational Sciences University of Oslo  Oslo Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103112773","display_name":"Morten Carstens Moe","orcid":"https://orcid.org/0000-0002-2318-2017","observed_orcids":["https://orcid.org/0000-0002-2318-2017"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Morten Carstens Moe","raw_affiliation_strings":["Department of Ophthalmology Oslo University Hospital  Oslo Norway","Institute of Clinical Medicine, Faculty of Medicine University of Oslo  Oslo Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Oslo University Hospital  Oslo Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"Institute of Clinical Medicine, Faculty of Medicine University of Oslo  Oslo Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111121785","display_name":"Erik Magnus S\u00e6ther","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erik Magnus S\u00e6ther","raw_affiliation_strings":["Oslo Economics  Oslo Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo Economics  Oslo Norway","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004263190","display_name":"\u00d8ystein Kalsnes J\u00f8rstad","orcid":"https://orcid.org/0000-0003-1259-0653","observed_orcids":["https://orcid.org/0000-0003-1259-0653"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"\u00d8ystein Kalsnes J\u00f8rstad","raw_affiliation_strings":["Department of Ophthalmology Oslo University Hospital  Oslo Norway","Institute of Clinical Medicine, Faculty of Medicine University of Oslo  Oslo Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Oslo University Hospital  Oslo Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"Institute of Clinical Medicine, Faculty of Medicine University of Oslo  Oslo Norway","institution_ids":["https://openalex.org/I184942183"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004263190"],"corresponding_institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":7.4387,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.92527564,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"104","issue":"5","first_page":"551","last_page":"558"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.020500000566244125,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9760000109672546},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8410000205039978},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9110000133514404},{"id":"https://openalex.org/keywords/intravitreal-injection-frequency","display_name":"intravitreal injection frequency","score":0.7369999885559082},{"id":"https://openalex.org/keywords/cost-minimization-analysis","display_name":"cost-minimization analysis","score":0.6549999713897705},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.5979999899864197},{"id":"https://openalex.org/keywords/prefilled-syringes","display_name":"prefilled syringes","score":0.777999997138977},{"id":"https://openalex.org/keywords/cost-efficiency","display_name":"cost efficiency","score":0.5820000171661377},{"id":"https://openalex.org/keywords/norway","display_name":"Norway","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.9110999703407288},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9071000218391418},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6518999934196472},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.5077000260353088},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.46970000863075256},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43529999256134033},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.414000004529953},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3977999985218048},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.3756999969482422},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.32910001277923584},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.29429998993873596},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2922999858856201},{"id":"https://openalex.org/C2779354088","wikidata":"https://www.wikidata.org/wiki/Q15467261","display_name":"Degeneration (medical)","level":2,"score":0.2921999990940094},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.28439998626708984},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2840999960899353},{"id":"https://openalex.org/C3017566137","wikidata":"https://www.wikidata.org/wiki/Q5308929","display_name":"Drug usage","level":3,"score":0.27459999918937683},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.267300009727478},{"id":"https://openalex.org/C2986900798","wikidata":"https://www.wikidata.org/wiki/Q5308926","display_name":"Drug treatment","level":2,"score":0.25920000672340393},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25450000166893005}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009664","descriptor_name":"Norway","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009664","descriptor_name":"Norway","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009664","descriptor_name":"Norway","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/aos.70069","doi":"https://doi.org/10.1111/aos.70069","is_oa":true,"landing_page_url":"https://doi.org/10.1111/aos.70069","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aos.70069","source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"},{"id":"pmid:41622479","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41622479","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta ophthalmologica","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13353565","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41622479/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13353565/pdf/AOS-104-551.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Acta Ophthalmol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/aos.70069","doi":"https://doi.org/10.1111/aos.70069","is_oa":true,"landing_page_url":"https://doi.org/10.1111/aos.70069","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aos.70069","source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5546517372131348}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7127044335.pdf","grobid_xml":"https://content.openalex.org/works/W7127044335.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1782061354","https://openalex.org/W2171962482","https://openalex.org/W2953647828","https://openalex.org/W2989847831","https://openalex.org/W2998581411","https://openalex.org/W3130360177","https://openalex.org/W3146812839","https://openalex.org/W4389522238","https://openalex.org/W4391930651","https://openalex.org/W4392545215","https://openalex.org/W4399170971","https://openalex.org/W4399954953","https://openalex.org/W4403403414","https://openalex.org/W4405790569","https://openalex.org/W4405825252","https://openalex.org/W4412551260","https://openalex.org/W4414866649"],"related_works":[],"abstract_inverted_index":{"PURPOSE:":[0],"Norwegian":[1,56],"guidelines":[2],"designate":[3],"off-label":[4],"Avastin":[5,119,175,186],"as":[6,108,110],"the":[7,76,81,111,152,156,188],"first-line":[8],"intravitreal":[9],"therapy":[10],"for":[11,210,220],"neovascular":[12],"age-related":[13],"macular":[14],"degeneration":[15],"(nAMD)":[16],"because":[17],"of":[18,84,114],"its":[19,193],"well-documented":[20],"clinical":[21,129],"efficacy":[22],"and":[23,69,71,106,138,179,231],"low":[24],"price.":[25],"However,":[26],"this":[27],"overlooks":[28],"non-drug":[29,198],"costs,":[30],"which":[31],"increase":[32],"with":[33],"injection":[34,126,195,204,229],"frequency.":[35],"We":[36,59,124],"evaluated":[37],"whether":[38],"newer,":[39],"longer-acting":[40,226,241],"agents":[41,227],"offer":[42],"greater":[43],"long-term":[44,247],"cost-efficiency":[45,245],"by":[46,164],"reducing":[47],"total":[48,208],"costs":[49,73,209],"despite":[50],"higher":[51],"drug":[52,190],"prices":[53],"in":[54,74,90,246,250],"a":[55,61,217],"setting.":[57],"METHODS:":[58],"developed":[60],"2-year":[62],"cost-minimization":[63],"model":[64,94],"that":[65,203,239],"included":[66],"pharmaceutical,":[67],"consultation":[68],"administrative":[70],"patient-related":[72],"Norway;":[75],"pharmaceutical":[77],"cost":[78,146,159],"component":[79],"incorporated":[80],"routine":[82],"practice":[83,113],"splitting":[85],"vials":[86],"into":[87],"prefilled":[88],"syringes":[89],"hospital":[91],"pharmacies.":[92],"The":[93],"compared":[95],"four":[96],"nAMD":[97,248],"monotherapies,":[98],"Avastin,":[99],"Eylea":[100,103,121,165,180],"2":[101,122,150,166],"mg,":[102],"8":[104,181],"mg":[105,167,182],"Vabysmo,":[107],"well":[109],"common":[112],"switching":[115,153],"treatment-resistant":[116],"patients":[117],"from":[118,128],"to":[120,143],"mg.":[123],"derived":[125],"frequencies":[127],"trials":[130],"(for":[131,136],"monotherapies)":[132],"or":[133],"observational":[134],"data":[135],"switching)":[137],"conducted":[139],"one-way":[140],"sensitivity":[141],"analyses":[142,201],"identify":[144],"key":[145],"drivers.":[147],"RESULTS:":[148],"Over":[149],"years,":[151],"regimen":[154],"had":[155,187,216],"highest":[157],"per-patient":[158],"(146":[160],"722":[161],"NOK),":[162,170,174],"followed":[163],"(100":[168],"481":[169],"Vabysmo":[171],"(93":[172],"207":[173],"(86":[176],"262":[177],"NOK)":[178],"(68":[183],"738":[184],"NOK).":[185],"lowest":[189],"cost,":[191],"but":[192],"high":[194],"frequency":[196,205,230],"increased":[197],"costs.":[199,235],"Sensitivity":[200],"showed":[202],"strongly":[206],"influenced":[207],"high-priced":[211],"drugs,":[212],"while":[213],"patient":[214],"time":[215],"substantial":[218],"impact":[219],"Avastin.":[221],"CONCLUSION:":[222],"In":[223],"our":[224],"model,":[225],"reduced":[228],"decreased":[232],"overall":[233],"treatment":[234],"These":[236],"findings":[237],"suggest":[238],"adopting":[240],"monotherapy":[242],"could":[243],"improve":[244],"management":[249],"Norway.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2026-02-03T00:00:00"}